Latest California Healthline Stories
Patients Experiment With Prescription Drugs To Fight Aging
Doctors and patients say they’re compelled to use off-label meds as research goes unfunded.
Americans Cross Border Into Mexico To Buy Insulin At A Fraction Of U.S. Cost
For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico. But is it legal?
Listening To Older Patients Who Want To Stop Dialysis
Older adults with advanced kidney disease sometimes want to stop dialysis but often meet resistance from doctors, new research shows. We explore options available to these patients, including conservative care.
Adultos mayores vulnerables logran volver a ser independientes
El programa para personas mayores vulnerables de bajos ingresos Community Aging in Place — Advancing Better Living for Elders (CAPABLE) ayuda a los abuelos a vivir independientemente.
Frail Seniors Find Ways To Live Independently
A pilot program for frail low-income seniors provides much-needed help in dealing with “daily activities” and offers practical solutions.
Why The U.S. Remains The World’s Most Expensive Market For ‘Biologic’ Drugs
Biologic drugs, made from living organisms, are big moneymakers partly because they have little competition from “biosimilars.” It’s a very different story in Europe.
Por qué los adultos mayores necesitan consumir más proteína
La cantidad de proteínas, y las formas de consumirla, son distintas en las personas mayores. Su carencia impacta fuerte en su masa muscular.
Why Older Adults Should Eat More Protein (And Not Overdo Protein Shakes)
Whether because of illness or inactivity, many seniors need to up their protein game to maintain strength and mobility.
Podcast: KHN’s ‘What The Health?’ Is Health Spending The Next Big Political Issue?
Diabetics dying because they can’t afford insulin. Organ transplant patients undergoing “wallet biopsies” to get on waiting lists. Are out-of-pocket costs going to dominate the health discussion in the next election? Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss this as well as new Trump administration rules giving states the ability to make major changes to the Affordable Care Act. Also, lame-duck lawmakers in Wisconsin and Michigan try to cement health changes before Democrats take over.
Chronically Ill, Traumatically Billed: The $123,000 Medicine For MS
Shereese Hickson’s doctor wanted her to try the infusion drug Ocrevus for her multiple sclerosis. Even though Hickson is trained as a medical billing coder, she was shocked to see two doses of the drug priced at $123,019, with her share set at $3,620.